Sign in →

Test Code CARU Cyclic Adenosine Monophosphate (cAMP), Urinary Excretion, Serum and Urine


Specimen Required


Both serum and urine are required. Serum must be obtained at the time of the urine collection.

 

Specimen Type: Serum

Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL

Collection Instructions:

1. Serum gel tubes should be centrifuged within 2 hours of collection.

2. Red-top tubes should be centrifuged, and the serum aliquoted into a plastic vial within 2 hours of collection.

3. Label specimen as serum.

 

Specimen Type: Urine

Supplies: Sarstedt Aliquot Tube, 5 mL (T914)

Container/Tube: Plastic vial

Specimen Volume: 5 mL

Collection Instructions:

1. Collect a random urine specimen.

2. Label specimen as urine.


Useful For

Differential diagnosis of hypercalcemia

 

As an adjunct to serum parathyroid hormone measurements, especially in the diagnosis of parathyroid hormone resistance states, such as pseudohypoparathyroidism

Profile Information

Test ID Reporting Name Available Separately Always Performed
ACREA Creatinine, S Yes, (order CRTS1) Yes
CAMP Cyclic Amp, Urinary Excretion No Yes
CRETR Creatinine, Random, U Yes, (order RCTUR) Yes

Method Name

ACREA, CRETR: Enzymatic Colorimetric Assay

CAMP: Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

Reporting Name

Cyclic Amp, Urinary Excretion

Specimen Type

Serum
Urine

Specimen Minimum Volume

Serum: 0.5 mL
Urine: 2.0 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 7 days
  Frozen  90 days
Urine Refrigerated (preferred) 28 days
  Frozen  28 days

Reject Due To

Gross hemolysis Reject
Gross lipemia OK
Gross icterus OK

Clinical Information

Adenosine cyclic 3',5'-monophosphate (cAMP) functions as an intracellular "second messenger" regulating the activity of intracellular enzymes or proteins in response to a variety of hormones (eg, parathyroid hormone).

 

Urinary cAMP is elevated in about 85% of patients with hyperparathyroidism.

Reference Values

CYCLIC AMP

1.3-3.7 nmol/dL of glomerular filtrate

 

CREATININE, SERUM

Males

0-11 months: 0.17-0.42 mg/dL

1-5 years: 0.19-0.49 mg/dL

6-10 years: 0.26-0.61 mg/dL

11-14 years: 0.35-0.86 mg/dL

≥15 years: 0.74-1.35 mg/dL

 

Females

0-11 months: 0.17-0.42 mg/dL

1-5 years: 0.19-0.49 mg/dL

6-10 years: 0.26-0.61 mg/dL

11-15 years: 0.35-0.86 mg/dL

≥16 years: 0.59-1.04 mg/dL

 

CREATININE, URINE

No reference values apply. Interpret with other clinical data.

Interpretation

Urinary adenosine cyclic 3',5'-monophosphate (cAMP) is elevated in about 85% of patients with hyperparathyroidism and in about 50% of patients with humoral hypercalcemia of malignancy.

Cautions

Parathyroid suppression (hypoparathyroidism) does not lower urinary adenosine cyclic 3',5'-monophosphate (cAMP) excretion to definitively subnormal values.

Method Description

Adenosine 3',5'-cyclic monophosphate (cAMP) is isolated from the urine using a single anion exchange column. An internal standard (8-methyl amino cAMP) is used to correct for recovery losses. Once the cAMP has been eluted from the column, it is added to a solution and injected onto the liquid chromatography tandem mass spectrometry system. Quantitation is by peak area measurement against a calibration standard containing known quantities of cAMP and internal standard. Urine and serum creatinine levels are used to determine the clearance of cAMP from the kidneys.(Unpublished Mayo method)

 

Creatinine:

The enzymatic method is based on the determination of sarcosine from creatinine with the aid of creatininase, creatinase, and sarcosine oxidase. The liberated hydrogen peroxide is measured via a modified Trinder reaction using a colorimetric indicator. Optimization of the buffer system and the colorimetric indicator enables the creatinine concentration to be quantified both precisely and specifically.(Package insert: Creatinine plus v2. Roche Diagnostics; V15.0, 03/2019)

Day(s) Performed

Wednesday

Report Available

2 to 10 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

82030

82570

82565

LOINC Code Information

Test ID Test Order Name Order LOINC Value
CARU Cyclic Amp, Urinary Excretion 21052-6

 

Result ID Test Result Name Result LOINC Value
179 Cyclic Amp, Urinary Excretion 22712-4
ACREA Creatinine, S 2160-0
CRETR Creatinine, Random, U 2161-8